Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E W Steyerberg

Showing results (31-40 of 231) with videos related to

Pageof 24
Sort By:
Acta Orthopaedica Scandinavica|May 1, 2001
Reliability of the AO/ASIF classification for pertrochanteric femoral fracturesI B Schipper, E W Steyerberg, R M Castelein, et al.
Gynecologic Oncology Reports|December 21, 2016
Flawed external validation study of the ADNEX model to diagnose ovarian cancerB Van Calster, E W Steyerberg, T Bourne, et al.
Acta Neurochirurgica. Supplement|February 9, 2006
Mortality from traumatic brain injuryJ Lu, A Marmarou, S Choi, et al.
Annals of Vascular Surgery|January 9, 2009
What is the evidence on efficacy of spinal cord stimulation in (subgroups of) patients with critical limb ischemia?H M Klomp, E W Steyerberg, J D F Habbema, et al.
Drugs|July 17, 1998
Reperfusion therapy for acute myocardial infarction. Which strategy for which patient?E Boersma, E W Steyerberg, M J Van der Vlugt, et al.
Gut|November 12, 2010
Predictors for outcome of failure of balloon dilatation in patients with achalasiaJ Alderliesten, J M Conchillo, I Leeuwenburgh, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|January 4, 2006
Spinal cord stimulation is not cost-effective for non-surgical management of critical limb ischaemiaH M Klomp, E W Steyerberg, H van Urk, et al.
Journal of Clinical Epidemiology|October 22, 2003
Clinical prediction rule for 30-day mortality in Björk-Shiley convexo-concave valve replacementM J van Gorp, E W Steyerberg, M Kallewaard, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 13, 1999
[Results of 15 years of treatment of nonseminoma testicular cancer: 84% 5-year survival rate]L R van Veelen, E W Steyerberg, F J Cleton, et al.
American Journal of Public Health|June 1, 1997
Routine prenatal screening for congenital heart disease: what can be expected? A decision-analytic approachE Buskens, E W Steyerberg, J Hess, et al.
Pageof 24

Showing results (31-40 of 231) with videos related to

Sort By:
Pageof 24
Acta Orthopaedica Scandinavica|May 1, 2001
Reliability of the AO/ASIF classification for pertrochanteric femoral fracturesI B Schipper, E W Steyerberg, R M Castelein, et al.
Gynecologic Oncology Reports|December 21, 2016
Flawed external validation study of the ADNEX model to diagnose ovarian cancerB Van Calster, E W Steyerberg, T Bourne, et al.
Acta Neurochirurgica. Supplement|February 9, 2006
Mortality from traumatic brain injuryJ Lu, A Marmarou, S Choi, et al.
Annals of Vascular Surgery|January 9, 2009
What is the evidence on efficacy of spinal cord stimulation in (subgroups of) patients with critical limb ischemia?H M Klomp, E W Steyerberg, J D F Habbema, et al.
Drugs|July 17, 1998
Reperfusion therapy for acute myocardial infarction. Which strategy for which patient?E Boersma, E W Steyerberg, M J Van der Vlugt, et al.
Gut|November 12, 2010
Predictors for outcome of failure of balloon dilatation in patients with achalasiaJ Alderliesten, J M Conchillo, I Leeuwenburgh, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|January 4, 2006
Spinal cord stimulation is not cost-effective for non-surgical management of critical limb ischaemiaH M Klomp, E W Steyerberg, H van Urk, et al.
Journal of Clinical Epidemiology|October 22, 2003
Clinical prediction rule for 30-day mortality in Björk-Shiley convexo-concave valve replacementM J van Gorp, E W Steyerberg, M Kallewaard, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 13, 1999
[Results of 15 years of treatment of nonseminoma testicular cancer: 84% 5-year survival rate]L R van Veelen, E W Steyerberg, F J Cleton, et al.
American Journal of Public Health|June 1, 1997
Routine prenatal screening for congenital heart disease: what can be expected? A decision-analytic approachE Buskens, E W Steyerberg, J Hess, et al.
Pageof 24